Immunome, Inc. Announces Chief Financial Officer Changes, Effective January 2, 2024
Position
Chief Financial Officer
Company
Immunome Inc.
BothellBiotechnologyHealth CareMedicalTherapeuticsDescription
The Company's board of directors has, effective as of the Roche Separation Date, appointed Max Rosett, in addition to his other titles, as the Company's Interim Chief Financial Officer and principal financial officer.
Quick answer
Immunome, Inc. Announces Chief Financial Officer Changes, Effective January 2, 2024 (December 30, 2023). Immunome Inc. is based in Bothell, Washington, United States.
- What did Immunome Inc. announce on December 30, 2023?
- The Company's board of directors has, effective as of the Roche Separation Date, appointed Max Rosett, in addition to his other titles, as the Company's Interim Chief Financial Officer and principal financial officer.
- What does Immunome Inc. do?
- Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies.
- Where is Immunome Inc. based?
- Immunome Inc. is based in Bothell, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Scorpion Therapeutics (January 4, 2024), Novocure (January 4, 2024), Compugen (January 22, 2024) and Mirai Medical (January 23, 2024) also announced leadership changes within 45 days of Immunome Inc.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as Chief Executive Officer and Expands Leadership Team (January 4, 2024)
- Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer (January 4, 2024)
- Compugen Welcomes Kara Rudy as Vice President, Marketing (January 22, 2024)
- Mirai Medical Welcomes Former Boston Scientific Executive, David A. Pierce, as Non-Executive Director (January 23, 2024)
- Myeloid Announces Appointment of Matthew Maurer, M.D. as Chief Medical Officer (December 6, 2023)
- TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer (December 4, 2023)
Who to call at Immunome Inc., and when
A new leader at Immunome Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Immunome Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Immunome Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunome Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunome Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Immunome Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.